Marex Group’s Bone Biologics Corp Warrants BBLGW Stock Holding History

Marex Group’s Portfolio BBLGW Stock Details BBLGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,460	Closed	-$44.9K	–	518
2023 Q4	$44.9K	Buy	+11,460	New	+$37.8K	﹤0.01%	526

Other funds holding BBLGW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marex Group's BBLGW Position: Q1 2024 in Review

Marex Group sold out of Bone Biologics Corp Warrants (BBLGW) in Q1 2024, closing a stake of 11,460 shares — an estimated $44.9K sold.

Marex Group first reported a position in BBLGW in Q4 2023 and held it in 1 quarter. The position peaked at $44.9K in Q4 2023. 3 funds tracked by Wall St. Rank hold BBLGW as of Q1 2024.

Marex Group reported no remaining Bone Biologics Corp Warrants position as of Q1 2024 after selling out during the quarter.
Marex Group sold 11,460 Bone Biologics Corp Warrants shares in Q1 2024, an estimated $44.9K.
Marex Group first reported a position in Bone Biologics Corp Warrants in Q4 2023 and held it in 1 quarter.
Marex Group's Bone Biologics Corp Warrants position peaked at $44.9K in Q4 2023.
3 funds tracked by Wall St. Rank held Bone Biologics Corp Warrants as of Q1 2024.

Based on Marex Group's 13F filing for Q1 2024, filed 2 Apr 2026.